cx-072
Showing 1 - 3 of 3
Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)
Completed
- Solid Tumor
- Lymphoma
- CX-072
- +2 more
-
Los Angeles, California
- +30 more
Feb 7, 2022
Solid Tumor, Unresectable or Metastatic Melanoma Trial in Worldwide (CX-072, Ipilimumab)
Terminated
- Solid Tumor
- Unresectable or Metastatic Melanoma
- CX-072
- Ipilimumab
-
Duarte, California
- +26 more
Nov 2, 2021